A Phase 1 Clinical Study With Influenza Antiviral DAS181-F04: Double-Blind, Randomized, Placebo-Controlled, Multi Dose Study in Healthy Adults
Phase of Trial: Phase I
Latest Information Update: 08 Mar 2017
At a glance
- Drugs DAS 181 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions
- 26 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 03 Aug 2012 New trial record